Everist Health is a closely held, privately owned company, headquartered in Ann Arbor, Michigan. The principle shareholders of Everist Health are large family investment offices headquartered in Denver, Colorado; Sioux Falls, South Dakota; New York City and Naples, Florida.
Everist Health was formed two years ago by combining the assets, product portfolios, capabilities and IP of Genetics Squared, Inc. and Angiologix Inc. Everist Health has successfully completed several cash-based company and product acquisitions, all financed by the current family office shareholder base. Everist Health's patent protected products aid physicians in early diagnosis of diseases (such as cancer, cardiovascular disease and metabolic disease), long before there are any detectable symptoms and thereby enabling early and more effective treatment while also reducing healthcare costs and saving lives.
Example of an Everist Health product:
AngioDefender™: a non-invasive sensor technology device for the early diagnosis of atherosclerosis and cardiovascular disease years before a patient has detectable symptoms.